FDA Commissioner Rob Califf Emphasizes Need to Combat Misinformation

August 24, 2022

Rob Califf, the commissioner of the US Food and Drug Administration (FDA), spoke about his current goals for the agency. Califf emphasized the need to continue focusing on the ongoing COVID-19 pandemic and the opioid epidemic. The nation is behind its peers in terms of vaccinations, and Americans are growing increasingly tired of COVID-19 restrictions.

According to Califf, “The clinical community must remain resilient and work toward more equitable delivery of evidence-based therapies. Substantial disparities in COVID-19 vaccination rates and use of therapeutics will be closed only with a proactive approach by clinicians. Furthermore, the US public has been exposed to highly variable recommendations on social media and in professional circles about COVID-19 treatment and prevention. Broad collaboration is needed across clinical communities to promote reliable information about lifesaving vaccinations and treatments and counter the spread of medical misinformation.”

To read more, click here.